Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
$210.00 10 in stock 10 in stock This product is intended for laboratory research use only
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
What does GHK-Cu peptide injection do
A preliminary study in search of potential peptide candidates for a combinational therapy with cancer chemotherapy drug
Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
US$ 20.67
US$ 24.95
US$ 27.26
US$ 20.61
US$ 23.93